Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Medical Marijuana I (OP: MJNA ) 0.0010 UNCHANGED Streaming Delayed Price Updated: 3:57 PM EDT, Sep 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 0.0010 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0010 Today's Range 0.0010 - 0.0010 52wk Range 0.0001 - 0.0071 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains September 09, 2024 Trump confirmed his support for recreational cannabis in Florida. and sparked a reaction in the cannabis stock market on Monday. Via Benzinga Topics Cannabis Government Exposures Cannabis Political Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit? September 05, 2024 Stocks in the cannabis sector showed varied reactions on Wednesday, after Trump's comments on the legalization of marijuana in Florida. Via Benzinga Topics Cannabis Government Exposures Cannabis Political Performance YTD -71.43% -71.43% 1 Month -23.08% -23.08% 3 Month -37.50% -37.50% 6 Month -56.52% -56.52% 1 Year -83.87% -83.87% More News Read More Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research June 26, 2024 Via NewMediaWire Topics Cannabis Exposures Cannabis Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research June 26, 2024 Via TheNewswire.com Topics Cannabis Exposures Cannabis Easy-To-Trade Cannabis Stocks: Insights Into How Trading Activity Affects These Investments May 20, 2024 Via Benzinga Topics Cannabis Exposures Cannabis Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red? May 20, 2024 Via Benzinga Topics Cannabis Exposures Cannabis NY Supreme Court's Landmark Ruling Upholds Medical Marijuana Patient's Rights Under Human Rights Law April 30, 2024 Via Benzinga Topics Cannabis Exposures Cannabis Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company August 01, 2023 From Medical Marijuana, Inc. Via Business Wire Historic Ruling To Legalize Cannabis Cultivation In Brazil: These Weed Companies Will Likely Benefit March 21, 2023 Via Benzinga Key Marijuana Executive Changes You Should Know About, New Appointments & More March 21, 2023 Via Benzinga Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion March 14, 2023 Via NewMediaWire Topics Cannabis Exposures Cannabis CBD For Traumatic Brain Injuries? Oral Administration Reduces Levels Of Neuronal Death In Animal Model, New Study February 06, 2023 Via Benzinga Medical Marijuana, Inc. Participates in Preclinical Research Study on Therapeutic Benefits of CBD on Traumatic Brain Injuries February 06, 2023 Via NewMediaWire Topics Cannabis Economy Exposures Cannabis Supply Chain Medical Marijuana Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point January 24, 2023 Via Benzinga Medical Marijuana, Inc. Subsidiary HempMeds Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point January 24, 2023 Via NewMediaWire Topics Cannabis Economy Lawsuit Exposures Cannabis Financial Legal Key Cannabis Exec Changes You Need To Know About: Dutchie Taps New CEO, Illinois' New Cannabis Officer & More December 02, 2022 Via Benzinga Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology November 29, 2022 Via NewMediaWire Topics Cannabis Economy Exposures Cannabis Supply Chain Medical Marijuana Q3 Revenue Declines 37% Sequentially, Here Are The Details November 22, 2022 Via Benzinga Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results November 22, 2022 Via NewMediaWire Topics Cannabis Economy Exposures Cannabis Supply Chain Medical Marijuana, Inc. Subsidiary HempMeds Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets November 01, 2022 Via NewMediaWire Topics Cannabis Economy Exposures Cannabis Supply Chain Argentina's 'Cannabis Conicet' Public Company Seeks To Strengthen The Industry In South America October 20, 2022 Via Benzinga Medical Marijuana, Inc. Subsidiary HempMeds Mexico Celebrates Successful Sponsorship of 2022 XII Latin American Congress of Epilepsy in Medellin, Colombia October 20, 2022 Via NewMediaWire Topics Cannabis Economy Exposures Cannabis Supply Chain Medical Marijuana, Inc. Subsidiary HempMeds Mexico Undertakes Promising CBD Research For Parkinson's Treatment October 12, 2022 Via Benzinga Medical Marijuana, Inc. Subsidiary HempMeds Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson's Disease Treatment October 12, 2022 Via NewMediaWire Topics Cannabis Economy Exposures Cannabis Supply Chain Medical Marijuana, Inc. Enters Into Asset Purchase Agreement With MFINITY Global LLC; Appoints MFINITY President as Kannaway President October 04, 2022 Via NewMediaWire Topics Cannabis Economy Exposures Cannabis Supply Chain Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.